These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19345732)
1. Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. Mahaffey CM; Zhang H; Rinna A; Holland W; Mack PC; Forman HJ Free Radic Biol Med; 2009 Jun; 46(12):1650-7. PubMed ID: 19345732 [TBL] [Abstract][Full Text] [Related]
2. Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma. Mahaffey CM; Mahaffey NC; Holland W; Zhang H; Gandara DR; Mack PC; Forman HJ J Thorac Oncol; 2012 Jan; 7(1):34-9. PubMed ID: 22089114 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257 [TBL] [Abstract][Full Text] [Related]
4. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2. Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680 [TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Singh A; Boldin-Adamsky S; Thimmulappa RK; Rath SK; Ashush H; Coulter J; Blackford A; Goodman SN; Bunz F; Watson WH; Gabrielson E; Feinstein E; Biswal S Cancer Res; 2008 Oct; 68(19):7975-84. PubMed ID: 18829555 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism. Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117 [TBL] [Abstract][Full Text] [Related]
8. MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas. Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y Mol Med Rep; 2012 Oct; 6(4):705-8. PubMed ID: 22767273 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway. Chian S; Zhao Y; Xu M; Yu X; Ke X; Gao R; Yin L Anticancer Drugs; 2019 Sep; 30(8):838-845. PubMed ID: 31415285 [TBL] [Abstract][Full Text] [Related]
10. The role of c-Jun phosphorylation in EpRE activation of phase II genes. Levy S; Jaiswal AK; Forman HJ Free Radic Biol Med; 2009 Oct; 47(8):1172-9. PubMed ID: 19666106 [TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells. Zhang H; Liu H; Dickinson DA; Liu RM; Postlethwait EM; Laperche Y; Forman HJ Free Radic Biol Med; 2006 Apr; 40(8):1281-92. PubMed ID: 16631518 [TBL] [Abstract][Full Text] [Related]
12. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771 [TBL] [Abstract][Full Text] [Related]
13. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Maher JM; Dieter MZ; Aleksunes LM; Slitt AL; Guo G; Tanaka Y; Scheffer GL; Chan JY; Manautou JE; Chen Y; Dalton TP; Yamamoto M; Klaassen CD Hepatology; 2007 Nov; 46(5):1597-610. PubMed ID: 17668877 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522 [TBL] [Abstract][Full Text] [Related]
15. Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer. Tian Y; Wu K; Liu Q; Han N; Zhang L; Chu Q; Chen Y J Hematol Oncol; 2016 Sep; 9(1):83. PubMed ID: 27601007 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells. Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431 [TBL] [Abstract][Full Text] [Related]
17. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2. Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301 [TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance-associated protein 3 expression by diesel exhaust particle extract in human bronchial epithelial BEAS-2B cells. Le Vée M; Bacle A; Jouan E; Lecureur V; Potin S; Fardel O Toxicol In Vitro; 2019 Aug; 58():60-68. PubMed ID: 30898553 [TBL] [Abstract][Full Text] [Related]
19. Nrf2 regulates cell motility through RhoA-ROCK1 signalling in non-small-cell lung cancer cells. Ko E; Kim D; Min DW; Kwon SH; Lee JY Sci Rep; 2021 Jan; 11(1):1247. PubMed ID: 33441941 [TBL] [Abstract][Full Text] [Related]
20. Genistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter region. Liu X; Sun C; Liu B; Jin X; Li P; Zheng X; Zhao T; Li F; Li Q Oncotarget; 2016 May; 7(19):27267-79. PubMed ID: 27029077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]